Oncology Research and Treatment
Journal metrics
Annual Clarivate and SCImago indicators.
| Year | JCR | SJR | ||||
|---|---|---|---|---|---|---|
| IF | IF quartile | Rank (percentile) | SJR | SJR quartile | Rank (percentile) | |
| 2025 | 1.4 | Q4 | 14.1% | 0.482 | Q3 | 59.6% |
| 2024 | 1.6 | Q4 | 19.6% | 0.589 | Q2 | 67.8% |
| 2023 | 2.0 | Q3 | 31.7% | 0.521 | Q3 | 66.3% |
| 2022 | 2.4 | Q4 | 31.1% | 0.495 | Q3 | 66.0% |
| 2021 | 2.8 | Q4 | 39.9% | 0.624 | Q2 | 74.0% |
| 2020 | — | — | 0.553 | Q3 | 69.4% | |
| 2019 | — | — | 0.558 | Q3 | 70.5% | |
| 2018 | — | — | 0.546 | Q3 | 68.0% | |
Impact history
Annual SJR and Impact Factor trend.
SJRIF
Journal record
eISSN
2296-5262
ISSN
2296-5270
region
Western Europe
coverage
1978-1997, 2013-2026